"我们是初创企业，前期投资基本用在研发上，一般金融机构对我们这种缺乏抵押物、信用记录不全和规模不足企业的评价就是抗风险能力弱，因此很难融 到资金。"日前，深圳市龙华区某科创企业负责人李先生在获悉龙华产业资本投资有限公司（以下简称龙华资本）可通过对科技创新成果尽调评估，为企业 提供"龙华资本贷"支持后，主动带上资料来到龙华区双招双引党群服务中心了解相关情况。 李先生表示，科创企业从科研成果转化到市场产品推出往往是最艰难的一段时光，最需要稳定的资金保障，一旦无法突破就可能面临推倒重来的困局。 对此，龙华资本相关负责人表示，"龙华资本贷"就是龙华资本作为区属全资国有企业，在全面推动龙华区打造产融结合示范区背景下，基于一线企业调研情 况反馈，携手银行推出的投贷联动产品。 "龙华资本贷"是由龙华资本联合建设银行深圳分行定制发行规模20亿元的投贷联动产品，主要面向龙华资本以及龙华区引导基金已投的超200家深圳企业， 截至目前已累计服务氢蓝时代、通敏检测、木卫智能等十余家企业，完成审批额度超4000万元，切实缓解了企业融资难、融资贵、融资慢等痛点，为招商、 安商、稳商提供了有力支撑。 龙华资本"资本赋能·投贷联动"系列活动 ...

Key Takeaways Labcorp expanded its precision oncology portfolio with new solid tumor and hematologic cancer tests. LH added HRD testing and HER2 subtyping, and launched the Rapid AML Panel for advanced cancer profiling. Labcorp launched a global digital pathology platform to boost companion diagnostic development efforts.Labcorp (LH) recently announced the expansion of its precision oncology portfolio, which includes new test offerings for solid tumor and hematologic malignancies and enhanced biopharma so ...

Core Viewpoint - Inertial Labs, a subsidiary of VIAVI Solutions, has launched a Visual-Aided Inertial Navigation System (VINS) that allows aircraft to maintain accurate flight paths in environments where GPS/GNSS signals are unreliable [1][2]. Group 1: Product Features and Capabilities - VINS enables Unmanned Aerial Vehicles (UAVs) to perform long-range missions in GNSS-challenged environments, utilizing advanced 3D vision-based positioning software from Maxar® Raptor™ [2][3]. - The system can maintain horizontal positioning within 35 meters, vertical positioning within 5 meters, and velocity within 0.9 m/s in GNSS-denied environments. When GNSS is enabled, it achieves a horizontal position accuracy of 1 meter and a vertical position accuracy of less than 2 meters [4]. - VINS is designed for low-altitude operations and includes a modular system with processing and sensor modules, GNSS or CRPA antennas, and additional sensors for both fixed-wing and multi-rotor UAVs [5]. Group 2: Market Context and Demand - The launch of VINS coincides with a reported increase in GPS signal jamming and spoofing incidents, with up to 700 occurrences globally each day, particularly affecting commercial and military operations [2]. - The Lithuanian airspace alone recorded over 800 cases of GPS interference in the last three months of 2024, highlighting the growing need for reliable navigation systems in contested environments [2]. Group 3: Industry Events and Demonstrations - VINS and the second-generation RSR Transcoder will be showcased at the 2025 Joint Navigation Conference from June 2-5, where VIAVI will also present on various topics related to assured Positioning, Navigation, and Timing (PNT) in GPS-denied environments [6][7][9].

Fortive Corporation (FTV) has announced a significant expansion of its share repurchase efforts, reflecting strong confidence in its long-term growth prospects and disciplined capital allocation strategy.The company’s board of directors has authorized an increase of approximately 15.63 million shares under its general share repurchase program. This brings the total number of shares available for buyback to 20 million, including the 4.37 million shares remaining from prior authorizations. The general repurch ...

Company Overview - Fulgent Genetics, Inc. is a biotechnology company that specializes in diagnostic and genetic laboratory testing services and develops pharmaceutical treatments for various diseases and medical conditions [3] Allegations and Investigations - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Fulgent, stemming from allegations of providing potentially misleading business information to investors [1] - On February 28, 2025, Fulgent disclosed in its annual report that it received a civil investigative demand from the U.S. Department of Justice related to potential false claims submitted under the federal COVID-19 testing program for uninsured individuals [4] Market Reaction - Following the disclosure of the civil investigative demand, Fulgent's stock price declined by $0.41 per share, or approximately 2.61%, closing at $15.28 per share on March 3, 2025 [5]

PRESS RELEASE Neuilly-sur-Seine, France – May 28, 2025 Availability of preparatory documents for Bureau Veritas’ Combined Shareholders’ Meeting of June 19, 2025 Bureau Veritas’ Combined Shareholders’ Meeting will be held on Thursday, June 19, 2025, at 3:00 p.m., in the Auditorium of the Company’s registered office located at Immeuble Newtime, 40/52, boulevard du Parc in Neuilly-sur-Seine (92200), France, for the purpose of discussing the agenda and the draft resolutions contained in the preliminary Notice ...

Solution enables cost-effective retrofitting of legacy systems with industry-leading PNT resilienceCHANDLER, Ariz., May 28, 2025 /PRNewswire/ -- VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced the launch of its second-generation RSR Transcoder, created to maintain operational capability in GPS/GNSS-denied, degraded or disrupted space operational environments (D3SOE). The second generation RSR Transcoder delivers assured Position, Navigation and Timing (PNT) in a wide range of outputs to upgr ...

The Zacks Electronics – Testing Equipment industry has been suffering from a challenging global macroeconomic environment, end-market volatility, unfavorable forex and growing geo-political tensions. The sluggish automotive sector, due to declining investments in electric vehicles, has been a major headwind for industry participants. The factory automation end market has been weak, and the conservative capital expenditure spending trend across consumer electronics is a headwind. However, industry players li ...

Core Viewpoint - The company, Huicheng Co., Ltd. (688403), held a performance briefing on May 23, 2025, to discuss its operational performance and future strategies [1]. Group 1: Operational Performance - As of April 30, 2025, the company's overall capacity utilization rate was approximately 70%, remaining stable compared to the same period last year [2]. - The company's net profits for the years 2022 to 2024 were 177.225 million, 195.985 million, and 159.764 million respectively, indicating relatively stable profitability [3]. - In Q1 2025, the company reported a main revenue of 375 million, an increase of 18.8% year-on-year, and a net profit attributable to the parent company of 40.589 million, up 54.17% year-on-year [8]. Group 2: Strategic Initiatives - The company plans to enhance capacity utilization by expanding its customer base and improving market share, while also focusing on increasing the proportion of higher-margin products like MOLED and large-size display driver chip packaging [3]. - The company is actively advancing the production of new processes using copper-nickel-gold and palladium-gold, with expectations to complete capacity construction within the year and contribute to revenue [3]. - The company is utilizing convertible bond financing primarily for expanding the production capacity of advanced display driver chip packaging to meet the growing demand for OLED display driver chips [4]. Group 3: Customer Relationships and Market Position - The revenue contribution from the top five customers decreased from 48% to 37%, yet remains above the industry average, indicating a stable customer base [5]. - The company has established good relationships with major clients in the display driver chip sector, including BOE and Tesla, and is working on product introduction with Korean clients like Samsung and LG [5]. - The company has completed the construction of its automotive-grade chip project and is actively pursuing customer validation and product introduction [4][7]. Group 4: Financial Health - As of the end of Q1 2025, the company's consolidated asset-liability ratio was 30.34%, with sufficient cash reserves and good operating cash flow, indicating a strong debt repayment capability [4]. - The company has seen a net inflow of 224 million in financing over the past three months, with an increase in financing balance [9].

Core Viewpoint - Fulgent Genetics, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices, following a civil investigative demand from the U.S. Department of Justice regarding false claims submitted under the Uninsured Program [1][2]. Group 1: Company Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against Fulgent on behalf of its stockholders [1]. - The investigation is focused on whether Fulgent has engaged in unlawful business practices or violated federal securities laws [1]. - Following the disclosure of the civil investigative demand, Fulgent's stock price decreased by $0.41 per share, or 2.61%, closing at $15.28 per share [2]. Group 2: Legal Context - The civil investigative demand was received by Fulgent from the U.S. Department of Justice, indicating serious scrutiny regarding the company's claims under the Uninsured Program [2]. - The law firm Bragar Eagel & Squire, P.C. specializes in representing investors in complex litigation, which includes securities and derivative cases [4].